Adefovir
- Generic Name
- Adefovir
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C8H12N5O4P
- CAS Number
- 106941-25-7
- Unique Ingredient Identifier
- 6GQP90I798
- Associated Conditions
- -
- Associated Therapies
- -
A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)Adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease.
Phase 1
Completed
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 20
- Registration Number
- NCT00002115
- Locations
- 🇺🇸
Univ of Washington, Seattle, Washington, United States
The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected Patients
Phase 1
Completed
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 20
- Registration Number
- NCT00002326
- Locations
- 🇺🇸
Natl Cancer Institute, Bethesda, Maryland, United States
Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients
Phase 2
Completed
- Conditions
- First Posted Date
- 2001-03-29
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 30
- Registration Number
- NCT00013702
- Locations
- 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath